<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-046312</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Acromegaly, primary hyperparathyroidism and pheochromocytoma</dc:title>
<dc:description xml:lang="en">We present the case of a 56-year-old woman who, 5 years after receiving a diagnosis of unilateral adrenal pheochromocytoma and primary hyperparathyroidism, was diagnosed with acromegaly caused by a growth hormone-secreting pituitary adenoma. No germ-line mutations in RET, VHL and MEN-1 gene were detected. Medullar thyroid carcinoma was also ruled out. Therefore, the present case shows coexistence of a tumor characteristic of MEN 2 syndrome (pheochromocytoma) with a growth hormone-secreting pituitary tumor characteristic of MEN 1 syndrome and primary hyperparathyroidism, which can be observed in both multiple endocrine neoplasia syndromes, but without germ-line mutations in RET, VHL and MEN-1</dc:description>
<dc:creator>Lisbona Gil, Arturo </dc:creator>
<dc:creator>Fernández Riestra, Asís </dc:creator>
<dc:creator>Alonso Rodríguez, César </dc:creator>
<dc:creator>Robledo, Mercedes</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se presenta el caso de una mujer que 5 años después de haber sido diagnosticada de feocromocitoma adrenal derecho e hiperparatiroidismo primario, desarrolló una acromegalia por adenoma hipofisario. Se descartó la existencia de carcinoma medular de tiroides y de mutación germinal en RET y en VHL. La determinación del gen MEN-1 también resultó negativa. Se dan en este caso la existencia de un tumor característico de la NEM-2 como el feocromocitoma, otro característico de la NEM-1 como el adenoma hipofisario secretor de GH e hiperparatiroidismo primario, que se da en ambas neoplasias endocrinas múltiples, pero sin mutaciones germinales en RET, VHL y MEN-1</dc:description>
<dc:source>Endocrinol Nutr;53(6): 382-387, jun. 2006. tab</dc:source>
<dc:identifier>ibc-046312</dc:identifier>
<dc:title xml:lang="es">Acromegalia, hiperparatiroidismo primario y feocromocitoma</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7140^s22012</dc:subject>
<dc:subject>^d178^s22012</dc:subject>
<dc:subject>^d10868^s22012</dc:subject>
<dc:subject>^d6781^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23803^s22012</dc:subject>
<dc:subject>^d32134^s22016</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d32133^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>200606</dc:date>
</metadata>
</record>
</ibecs-document>
